List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 24 studies with search of: Chickenpox | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting The Effectiveness of Varicella Vaccination in Children in Germany
Condition: Varicella (Chickenpox)
Intervention: Procedure: Varicella (chickenpox) lesion sampling
2 Not yet recruiting Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery
Conditions: Varicella;   Hepatitis A
Interventions: Biological: Varicella Vaccine;   Biological: Hepatitis A Vaccine
3 Recruiting Immune Response to Varicella-Zoster Vaccination and Infection
Conditions: Chickenpox;   Herpes Zoster
Intervention:
4 Recruiting Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
Conditions: Liver Disease;   Liver Transplantation;   Varicella
Intervention: Biological: Vaccination with VZV vaccine
5 Available Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection
Condition: Varicella
Intervention: Drug: VariZIG™
6 Recruiting Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
Conditions: Measles Disease;   Mumps Disease;   Rubella Disease;   Varicella Disease
Interventions: Biological: Priorix-Tetra TM (combined measles-mumps-rubella-varicella vaccine);   Biological: GSK Biologicals' 208136, new formulation
7 Recruiting Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: VarilrixTM;   Biological: PriorixTM;   Biological: GSK Biologicals' vaccine 208136
8 Recruiting Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: GSK Biological's investigational MMRV vaccine 208136;   Biological: Varilrix™;   Biological: Priorix™
9 Recruiting Efficacy of TCA Effect on Varicella Atrophic Scars
Condition: Atrophic Varicella Scar
Intervention: Drug: 70% trichloroacetic acid
10 Recruiting Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
Condition: Diseases Caused by Measles, Mumps, Rubella and Varicella Viruses
Interventions: Biological: M-M-R® II (Merck and Co);   Biological: Varivax®;   Biological: GSK Biological's investigational vaccine 209762;   Biological: Havrix®;   Biological: Prevnar®
11 Recruiting A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Comparator: Zostavax;   Biological: Comparator: Placebo
12 Recruiting Immune Response to Varicella Vaccination in Children With Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention:
13 Recruiting Re-examination Study For Varivax
Condition: Varicella
Intervention:
14 Recruiting The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
Conditions: Immunity;   Measles;   Mumps;   Rubella
Interventions: Dietary Supplement: Probiotics (L.acidophilus and B.lactis);   Dietary Supplement: Cornflor
15 Not yet recruiting Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation
Condition: Kidney Transplant
Interventions: Biological: Zostavax (Live attenuated herpes zoster vaccine);   Biological: Placebo vaccine
16 Recruiting The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Conditions: Herpesvirus;   Adenovirus;   Cytomegalovirus;   Human Papillomavirus;   Human Polyomavirus;   Respiratory Viruses
Intervention:
17 Recruiting Prospective Trial of Vaccine Responses in Childhood Cancer Survivors
Conditions: Childhood Cancer;   Multiple Diseases
Interventions: Biological: Immunization Schedule patients <7 years.;   Biological: Immunization Schedule patients > or = to 7 years and <11 years of age;   Biological: Immunization Schedule patients > or = to 11 years of age
18 Recruiting Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles
Conditions: Virus Diseases;   Herpes Zoster
Intervention:
19 Recruiting A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus;   Biological: OKAVAX®:Attenuated live varicella-zoster virus and AVAXIM® 80U: Hepatitis A virus Vaccines;   Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and Childhood vaccines;   Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and NaCl (Placebo)
20 Recruiting Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A
Condition: Herpes Zoster in Autologous Hematopoietic Stem Cell Transplantation Recipients
Interventions: Biological: Herpes Zoster Vaccine 1437173A;   Biological: Placebo vaccine (saline)

Previous Page Studies Shown (1-20) Next Page (21-24)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services